Delivery Order SPE2DB22D3102-SPE2DB24FL1WH

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The award, valued at $1,570.54, is a Firm Fixed Price Delivery Order contract with a completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $33,253.48 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565104486 - PROQUAD VIALS. The contract has a ceiling value of $1,601.99 and an ultimate completion date of July 25, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,570.54, has a completion date of July 31, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC enables the DLA to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,141.08 and a completion date of July 5, 2024. It is a Firm Fixed Price Delivery Order contract, which means the price will not change regardless of Amerisourcebergen's costs. The contract does not have a set-aside designation, indicating it was competed on a full and open basis....
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS pharmaceutical products to the U.S. government. The $1,601.99 firm fixed price Delivery Order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $3,115.18 and an ultimate completion date of September 18, 2023. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued up to $16,019.90 to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This Firm Fixed Price contract is for the supply of PROQUAD VIALS and has a period of performance through May 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of PROQUAD VIALS, a medical product. The $1,670.90 firm fixed price delivery order has an ultimate completion date of April 22, 2025 and does not utilize a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies, specifically "PROQUAD VIALS", to the U.S. federal government. The contract has a ceiling value of $1,601.99 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL1WH
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS medical products to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $4,711.62, is a Firm Fixed Price Delivery Order that runs through July 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000. This contract award does not have a set-aside designation.

Generated 9/30/24, 4:58 PM